- Description
- Details
- Reviews
Description
Details
The ExoSense CD63 Exosome ELISA Kit is designed as a direct enzyme-linked immunosorbent assay (ELISA) for the detection of whole exosomes that are immobilized onto the surface of wells of a microtiter plate. Detection is achieved using ExoSense CD63 Primary Antibody that specifically binds to exosomes, followed by HRP-conjugated ExoSense Secondary Antibody (goat-anti-mouse) to enhance the signal. The assay provides an accurate measurement of exosome particles per mL based on a standard curve of fibroblast derived exosomes of known concentration. Developed by ReCyte Therapeutics Inc, a subsidiary of BioTime, Inc.
Details
Details
| Size | EM2203 |
|---|---|
| Species | Human |
| Sample Types | Plasma, serum, and cell culture supernatants |
| Assay Time | Overnight recommended |
| Applications | |
| References | Tetta, C., et al. (2013) Extracellular vesicles as an emerging mechanism of cell-tocell communication. Endocrine 44(1): 11-19.Maguire, G. (2013) Stem cell therapy without the cells. Commun Integr Biol. 6(6): e26631.De Jong, O.G., et al. (2014) Extracellular vesicles: potential roles in regenerative medicine. Front Immunol 5: 608.Webber, J., et al. (2013) How pure are your vesicles? J Extracell Vesicles 2: 19861. |
